home / stock / til / til news

TIL News and Press, Instil Bio Inc. From 09/19/22

Stock Information
Company Name: Instil Bio Inc.
Stock Symbol: TIL
Market: NASDAQ
Website: instilbio.com
Menu
TIL TIL Quote TIL Short TIL News TIL Articles TIL Message Board
Get TIL Alerts

News, Short Squeeze, Breakout and More Instantly...
TIL - Instil Bio to Present at Jefferies Cell and Genetic Medicine Summit

DALLAS, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that company manag...
TIL - Instil Bio to Present at Morgan Stanley Global Healthcare Conference

DALLAS, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that company manag...

TIL - Instil Bio appoints Tim Moore as COO

Instil Bio ( NASDAQ: TIL ) has appointed Tim Moore to the role of COO. Mr. Moore most recently served as the President and COO of PACT Pharma, a cell therapy company focusing on neo-antigen directed TCR-T cell therapy. For further details see: Insti...

TIL - Instil Bio Announces Appointment of Tim Moore as Chief Operating Officer

DALLAS, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced the appointment of...
TIL - Instil Bio Non-GAAP EPS of -$0.40 beats by $0.01

Instil Bio press release ( NASDAQ: TIL ): Q2 Non-GAAP EPS of -$0.40 beats by $0.01 . As of June 30, 2022, the company had $354.6 million in total cash and cash equivalents and marketable securities, comprised of $42.5 million in cash and cash equivalents and $312.1 mil...

TIL - Instil Bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Cash runway expected to extend from 2024 into 2025 upon completion of anticipated sale-leaseback of Tarzana, CA manufacturing site DELTA-1 trial of ITIL-168 in advanced melanoma with registrational intent anticipated to complete enrollment in 1H 2023 with top-line clinical data ...

TIL - Abnormal Returns Of The Russell Index Reconstitution Anomaly: New 2022 Study

A new 2022/23 study continues the trading studies from 2017 testing abnormal Russell Index reconstitution returns from scholarly literature. Since 2017 the best return results from a price momentum test generated +57.90% in the first six months and average gains reached +29.04% in the...
TIL - ELMS, EMWP and EOSE among mid-day movers

Gainers: Electric Last Mile Solutions (ELMS) +195%. Advent Technologies Holdings (ADN) +185%. Sidus Space (SIDU) +60%. Pennsylvania Real Estate Investment (PEI) +39%. Vivakor (VIVK) +32%. Akero (AKRO) +24%. Revlon (REV) +23%. Zhong Yang Financial Group (TOP) +22%. Decisionpoint Systems (DPSI)...

TIL - MGNI, NRIX and PTGX are among after hour and movers

Gainers: Okta (OKTA) +14%. StoneCo  (STNE) +9%. Nurix Therapeutics (NRIX) +5%. Protagonist Therapeutics (PTGX) +5%. MacroGenics (MGNX) +5%. Losers: HashiCorp (HCP) -9%. JOANN (JOAN) -8%. Instil Bio (TIL) -5%. Magnite (MGNI) -5%. Zumiez  (ZUMZ) -4%. For further details se...

TIL - AVDL, SIGA, PSHG and IOVA among mid-day movers

Gainers: Avadel Pharmaceuticals (AVDL) +123%. SIGA Technologies (SIGA) +40%. Concert Pharmaceuticals (CNCE) +30%. Farfetch (FTCH) +25%. Allarity Therapeutics (ALLR) +25%. Merus N.V. (MRUS) +23%. Tenon Medical (TNON) +22%. Arcturus Therapeutics Holdings (ARCT) +19%. Red Rob...
Previous 10 Next 10